Company intelligence / Profile preview

Resolution

Edinburgh, Scotland, United Kingdom

Ownership: Private
Employees: ~51
Development stage: Other

Overview

Resolution Therapeutics is pioneering macrophage cell therapy for patients at risk of hepatic decompensation in chronic liver disease, aiming to provide an alternative to liver transplantation; clinical results are not yet publicly available, as programs are preclinical[1][2][4].

Therapeutic areas: ImmunologyGastroenterology
Modalities: Cell therapyMacrophage cell therapy
Industry: Biotech

Partnerships

Syncona Investment Management Limited

Beyond the preview

Go deeper on Resolution.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Resolution.

Explore the full profile